Tumor‐Informed ctDNA in Guiding First‐Line Immunochemotherapy in Advanced Non‐Small Cell Lung Cancers

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Increased blood-based intratumor heterogeneity (bITH) is associated with unfavorable outcomes of immune checkpoint inhibitors plus chemotherapy in non-small cell lung cancer2022 · 21 citations
2. 2Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA2023 · 85 citations
3. 3Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial2022 · 116 citations
4. 4VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research2016 · 1,102 citations
5. 5Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data2014 · 944 citations